It has been suggested that brain metabolic dysfunction is the primary driver of Alzheimer’s disease [35], making impairments in insulin signaling important for neurocognitive outcomes [36]. The gene discussed is INS; the disease is early-onset autosomal dominant Alzheimer disease.